173 related articles for article (PubMed ID: 29243368)
1. A 2000 patient retrospective assessment of a new strategy for burn wound management in view of infection prevention and treatment.
Glik J; Łabuś W; Kitala D; Mikuś-Zagórska K; Roberts CD; Nowak M; Kasperczyk A; Kawecki M
Int Wound J; 2018 Jun; 15(3):344-349. PubMed ID: 29243368
[TBL] [Abstract][Full Text] [Related]
2. Antiseptics for burns.
Norman G; Christie J; Liu Z; Westby MJ; Jefferies JM; Hudson T; Edwards J; Mohapatra DP; Hassan IA; Dumville JC
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011821. PubMed ID: 28700086
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic prophylaxis for preventing burn wound infection.
Barajas-Nava LA; López-Alcalde J; Roqué i Figuls M; Solà I; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Jun; (6):CD008738. PubMed ID: 23740764
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of Silver Sulfadiazine with other materials for healing and infection prevention in burns: A systematic review and meta-analysis.
Nímia HH; Carvalho VF; Isaac C; Souza FÁ; Gemperli R; Paggiaro AO
Burns; 2019 Mar; 45(2):282-292. PubMed ID: 29903603
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of silver nylon dressings with weak direct current on Pseudomonas aeruginosa-infected burn wounds.
Chu CS; McManus AT; Pruitt BA; Mason AD
J Trauma; 1988 Oct; 28(10):1488-92. PubMed ID: 3172311
[TBL] [Abstract][Full Text] [Related]
6. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
[TBL] [Abstract][Full Text] [Related]
7. Quantitative microbiology in the management of burn patients. II. Relationship between bacterial counts obtained by burn wound biopsy culture and surface alginate swab culture, with clinical outcome following burn surgery and change of dressings.
Steer JA; Papini RP; Wilson AP; McGrouther DA; Parkhouse N
Burns; 1996 May; 22(3):177-81. PubMed ID: 8726253
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns.
Muangman P; Pundee C; Opasanon S; Muangman S
Int Wound J; 2010 Aug; 7(4):271-6. PubMed ID: 20528992
[TBL] [Abstract][Full Text] [Related]
10. Treatment of paediatric burns with a nanocrystalline silver dressing compared with standard wound care in a burns unit: a cost analysis.
Cox SG; Cullingworth L; Rode H
S Afr Med J; 2011 Sep; 101(10):728-31. PubMed ID: 22272852
[TBL] [Abstract][Full Text] [Related]
11. Infection in burns.
Settle JA
J Hosp Infect; 1985 Sep; 6 Suppl B():19-29. PubMed ID: 2865307
[No Abstract] [Full Text] [Related]
12. Acetic acid dressings used to treat pseudomonas colonised burn wounds: A UK national survey.
Nour S; Reid G; Sathanantham K; Mackie I
Burns; 2022 Sep; 48(6):1364-1367. PubMed ID: 34862089
[TBL] [Abstract][Full Text] [Related]
13. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis.
Glik J; Kawecki M; Gaździk T; Nowak M
Pol Przegl Chir; 2012 Jan; 84(1):6-16. PubMed ID: 22472489
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and costs of nanocrystalline silver dressings versus 1% silver sulfadiazine dressings to treat burns in adults in the outpatient setting: A randomized clinical trial.
Moreira SS; Camargo MC; Caetano R; Alves MR; Itria A; Pereira TV; Lopes LC
Burns; 2022 May; 48(3):568-576. PubMed ID: 34688520
[TBL] [Abstract][Full Text] [Related]
15. The effects of honey compared to silver sulfadiazine for the treatment of burns: A systematic review of randomized controlled trials.
Aziz Z; Abdul Rasool Hassan B
Burns; 2017 Feb; 43(1):50-57. PubMed ID: 27576926
[TBL] [Abstract][Full Text] [Related]
16. The role of silver sulphadiazine in the conservative treatment of partial thickness burn wounds: A systematic review.
Heyneman A; Hoeksema H; Vandekerckhove D; Pirayesh A; Monstrey S
Burns; 2016 Nov; 42(7):1377-1386. PubMed ID: 27126813
[TBL] [Abstract][Full Text] [Related]
17. [Effect of silver nanoparticle dressing on second degree burn wound].
Chen J; Han CM; Lin XW; Tang ZJ; Su SJ
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):50-2. PubMed ID: 16620649
[TBL] [Abstract][Full Text] [Related]
18. The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds.
Boekema BK; Pool L; Ulrich MM
Burns; 2013 Jun; 39(4):754-9. PubMed ID: 23036845
[TBL] [Abstract][Full Text] [Related]
19. The role of alternative therapy in the management of partial thickness burns of the face--experience with the use of moist exposed burn ointment (MEBO) compared with silver sulphadiazine.
Ang ES; Lee ST; Gan CS; See P; Chan YH; Ng LH; Machin D
Ann Acad Med Singap; 2000 Jan; 29(1):7-10. PubMed ID: 10748957
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness of alginate silver dressing in outpatient management of partial-thickness burns.
Opasanon S; Muangman P; Namviriyachote N
Int Wound J; 2010 Dec; 7(6):467-71. PubMed ID: 20860635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
